Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study - Interim Results

Charis Charalampous, Shaji Kumar, Ricardo D. Parrondo, Saurabh Chhabra, Madhu Nagaraj, Mei Sheng Duh, Priyanka J. Bobbili, Aolin Wang, Jingyi Chen, Manasi Mohan, Patrick Hlavacek, Rickard Sandin, Joseph C. Cappelleri, David Hughes, Guido Nador, Marco DiBonaventura

Blood (2024) 144 (Supplement 1): 3770.

https://doi.org/10.1182/blood-2024-204005

Published: 2024

Journal Articles

An Indirect Comparison of Elranatamab's Progression-Free Survival, Duration of Response, and Overall Survival from MagnetisMM-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

Luciano J. Costa, Thomas W. LeBlanc, Hans Tesch, Pieter Sonneveld, Sarasa M.A. Johnson, Francis Vekeman, Patrick Hlavacek, Aster Meche, Paul Cislo, David Hughes, Guido Nador, Marco DiBonaventura

Blood (2024) 144 (Supplement 1): 2401.

https://doi.org/10.1182/blood-2024-203920

Published: 2024

Journal Articles

The Impact of Multiple Myeloma on Care Partner Well-Being, Work Productivity, and Resource Use in the United States and Western Europe

Kathy Annunziata, Nikoletta Sternbach, Hitomi Tanaka, Marco DiBonaventura, Joseph C. Cappelleri, Jack Watkins, David Hughes, Aster Meche, Chai Hyun Kim, C. Todd Kennedy, Hans Scheurer, Thomas W. LeBlanc

Blood (2024) 144 (Supplement 1): 3762.

https://doi.org/10.1182/blood-2024-201802

Published: 2024

Journal Articles

Real-World (RW) Evaluation of Acute Myeloid Leukemia (AML) Induction Therapies in the Community Setting: A Retrospective Evaluation of Outcomes of Intensive Chemotherapy, Venetoclax-Based Regimens, and Non-IC-Based Treatments

Keri Maher, Cherrishe Brown-Bickerstaff, Ali McBride, Ajeet Gajra, Djibril Liassou, Ying Qiu, Marné Garretson, JaLyna Laney, David Huggar, David Hughes

Blood (2022) 140 (Supplement 1): 13278–13279.

https://doi.org/10.1182/blood-2022-169762

Published: 2022

Journal Articles

Fe-Armacist Run Iron Deficiency Management Clinic to Optimize Intravenous Iron Infusions in an Ambulatory Oncology Clinic

Jessica Freydman, Maha AlDoughaim, Simon Gorelikov, Kimberly Tsou, Frances Blevins, John Mark Sloan, Radhika Jhaveri, David Hughes

Blood (2022) 140 (Supplement 1): 5003–5004.

https://doi.org/10.1182/blood-2022-158237

Published: 2022

Journal Articles

An Observational Study of Fostamatinib As Second Line Therapy in Adult Patients with Immune Thrombocytopenia (ITP) in Real-World Clinical Practice

David Hughes, Robert P. Numerof, Andrea Zider, Donna Chow, Ruchika Goel

Blood (2021) 138 (Supplement 1): 4223.

https://doi.org/10.1182/blood-2021-153144

Published: 2021

Journal Articles

Successful Conversion and Implementation to Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis

David Hughes, Lynnette Henshaw, Frances Blevins, Camille V Edwards, Adam Lerner, John Mark Sloan, Vaishali Sanchorawala

Blood (2021) 138 (Supplement 1): 1975.

https://doi.org/10.1182/blood-2021-147518

Published: 2021

Journal Articles

Droxidopa for Treatment of Refractory Orthostatic Hypotension in Patients with AL Amyloidosis: A Case Series

Jorge Nicolas Ruiz Lopez, Lisa M Mendelson, Tracy Joshi, David Hughes, Michelle C Kaku, Vaishali Sanchorawala, John Mark Mark Sloan

Blood (2021) 138 (Supplement 1): 4737.

https://doi.org/10.1182/blood-2021-151573

Published: 2021

Journal Articles

Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs

Charles J. Milrod, Frances Blevins, David Hughes, Adam Lerner, Shayna Sarosiek, Vaishali Sanchorawala, J. Mark Sloan

Blood (2021) 137 (21): 2987–2989.

https://doi.org/10.1182/blood.2021010853

Published: 2021

Includes: Supplemental data

Journal Articles

Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis

David Hughes, PharmD, Radhika Jhaveri, PharmD, Bhavesh Shah, RPh, Frances Blevins, PA-C, Alexamil Rodriguez, CPhT, Shayna Sarosiek, MD, Adam Lerner, MD, John Mark Sloan, MD, Vaishali Sanchorawala, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-135992

Published: 2020

Journal Articles

Incidence of Skin Hyperpigmentation in Black Patients Receiving Treatment with Immunomodulatory Medications

Frances Blevins, PA-C, David Hughes, PharmD, Charles Milrod, MD, Preya Patel, MD, Shayna DeMari, BA, Adam Lerner, MD, Shayna Sarosiek, MD, Vaishali Sanchorawala, MD, John Mark Sloan, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-136775

Published: 2020

Journal Articles

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD

Blood (2019) 134 (Supplement_1): 4912.

https://doi.org/10.1182/blood-2019-124740

Published: 2019

Journal Articles

Providing Diagnoses in Bone Marrow Failure Syndromes through Multimodal Comprehensive Genomic Evaluation and Multidisciplinary Care: The Melbourne Genomics Health Alliance Bone Marrow Failure Flagship

Georgina L Ryland, PhD, Lucy C Fox, MBBS FRACP FRCPA, Ella Thompson, PhD, Graham John Lieschke, PhD MBBS, FRACP, David Hughes, MD MRCP, Francoise Marie Mechinaud, MD FRACP, Anthea Louise Greenway, MBBS, Janine Campbell, MBBS, Erica M Wood, MBBS FRACP FRCPA, Jennifer Lickiss, PhD, Joel Wight, MBBS FRACP FRCPA, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Alison Trainer, MBBS, Elly Lynch, Melissa Martyn, Clara Gaff, David Ritchie, MBChB, PhD FRACP, FRCPA, Piers Blombery, MBBS

Blood (2018) 132 (Supplement 1): 3867.

https://doi.org/10.1182/blood-2018-99-114410

Published: 2018

NARROW

Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study - Interim Results

An Indirect Comparison of Elranatamab's Progression-Free Survival, Duration of Response, and Overall Survival from MagnetisMM-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

The Impact of Multiple Myeloma on Care Partner Well-Being, Work Productivity, and Resource Use in the United States and Western Europe

Real-World (RW) Evaluation of Acute Myeloid Leukemia (AML) Induction Therapies in the Community Setting: A Retrospective Evaluation of Outcomes of Intensive Chemotherapy, Venetoclax-Based Regimens, and Non-IC-Based Treatments

Fe-Armacist Run Iron Deficiency Management Clinic to Optimize Intravenous Iron Infusions in an Ambulatory Oncology Clinic

An Observational Study of Fostamatinib As Second Line Therapy in Adult Patients with Immune Thrombocytopenia (ITP) in Real-World Clinical Practice

Successful Conversion and Implementation to Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis

Droxidopa for Treatment of Refractory Orthostatic Hypotension in Patients with AL Amyloidosis: A Case Series

Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs

Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis

Incidence of Skin Hyperpigmentation in Black Patients Receiving Treatment with Immunomodulatory Medications

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

Providing Diagnoses in Bone Marrow Failure Syndromes through Multimodal Comprehensive Genomic Evaluation and Multidisciplinary Care: The Melbourne Genomics Health Alliance Bone Marrow Failure Flagship

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only